In summary, through our microRNA profiling in BC, we have found that FSCN1 might have an oncogenic function in BC and miR-145 and miR-133a might function as tumour suppressors through direct repression of FSCN1 in BC. This evidence concerns the gene FSCN1 and breast cancer.